Piasecki to lead Torre Lazur U.S. as Breitenbach exits

Share this article:
Torre Lazur McCann has appointed Marci Piasecki chief executive for its U.S. operations following the resignation of Beverley Breitenbach. Piasecki, who previously headed East Hanover, N.J.-based Echo Torre Lazur, reports to Richard Nordstrom, chairman and chief executive of Torre Lazur McCann Worldwide. She heads Torre Lazur McCann U.S. offices in Parsippany and East Hanover, N.J., San Diego and Chicago.
Piasecki worked for Torre Lazur McCann from 1992-2001, handling GlaxoSmithKline oncology and vaccine accounts, before joining Hyphen, where she headed client services. She re-joined Torre Lazur McCann in November, 2004.
Torre Lazur McCann said Breitenbach had resigned her post and "separately will announce future plans." Breitenbach could not be reached for this story.
Share this article:

Email Newsletters

More in Business Briefs

Avastin pockets another Priority Review label

It's the second for this cancer drug in two weeks.

Court invalidates some healthcare subsidies

The lawsuit has been wending its way through the courts for a while, and, although it is being deliberated in several other venues, the decision is part of a legal dispute that puts patients in the 36 states offering federal exchanges in limbo.

FDA generic division overhaul kicks in

The Food and Drug Administration has been intent on elevating and reorganizing its office of Generic Drugs since 2012.